These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28648283)

  • 1. 50 Years Ago in The Journal of Pediatrics: An Assessment of the Creatine Kinase Test in the Detection of Carriers of Duchenne Muscular Dystrophy.
    Cardon MW
    J Pediatr; 2017 Jul; 186():63. PubMed ID: 28648283
    [No Abstract]   [Full Text] [Related]  

  • 2. 50 years ago in the Journal of Pediatrics: the use of serum creatine phosphokinase and other serum enzymes in the diagnosis of progressive muscular dystrophy.
    Proud CM
    J Pediatr; 2013 Dec; 163(6):1656. PubMed ID: 24274203
    [No Abstract]   [Full Text] [Related]  

  • 3. An assessment of the creatine kinase test in the detection of carriers of Duchenne muscular dystrophy.
    Thompson MW; Murphy EG; McAlpine PJ
    J Pediatr; 1967 Jul; 71(1):82-93. PubMed ID: 5293863
    [No Abstract]   [Full Text] [Related]  

  • 4. 50 Years Ago in The Journal of Pediatrics: Pseudohypertrophic Muscular Dystrophy: Duchenne Type.
    Proud CM
    J Pediatr; 2015 Sep; 167(3):620. PubMed ID: 26319918
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of exercise on serum creatine kinase in carriers of Duchenne muscular dystrophy.
    Gaines RF; Pueschel SM; Sassaman EA; Driscoll JL
    J Med Genet; 1982 Feb; 19(1):4-7. PubMed ID: 7069744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creatine kinase activity in the detection of carriers of Duchenne muscular dystrophy: comparison of two methods.
    Tippett PA; Dennis NR; Machin D; Price CP; Clayton BE
    Clin Chim Acta; 1982 Jun; 121(3):345-59. PubMed ID: 7105400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of age on the detection rate in Duchenne muscular dystrophy.
    Zatz M; Otto PA
    J Neurol Sci; 1980 Sep; 47(3):407-10. PubMed ID: 7420114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle provocation test. A sensitive method for discrimination between carriers and noncarriers of Duchenne muscular dystrophy.
    Herrmann FH; Spiegler A; Wiedemann G
    Hum Genet; 1982; 61(2):102-4. PubMed ID: 7129438
    [No Abstract]   [Full Text] [Related]  

  • 9. Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases.
    Sibert JR; Harper PS; Thompson RJ; Newcombe RG
    Arch Dis Child; 1979 Jul; 54(7):534-7. PubMed ID: 485196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Duchenne muscular dystrophy in Germany, 1977-2011: A personal story.
    Scheuerbrandt G
    Muscle Nerve; 2018 Feb; 57(2):185-188. PubMed ID: 28981144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrier detection in Duchenne muscular dystrophy.
    Fitzsimmons JS; McLachlan JI; Reeves WG; Marriott DW; Woolfson AM; Mayhew J
    J Med Genet; 1980 Jun; 17(3):165-9. PubMed ID: 7401126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Duchenne muscular dystrophy carriers: quantitative echography and creatine kinasemia.
    Schapira G; Laugier P; Rochette J; Berger G; Katz P; Perrin J
    Hum Genet; 1987 Jan; 75(1):19-23. PubMed ID: 3542803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural History of Serum Enzyme Levels in Duchenne Muscular Dystrophy and Implications for Clinical Practice.
    Rodríguez-Cruz M; Almeida-Becerril T; Atilano-Miguel S; Cárdenas-Conejo A; Bernabe-García M
    Am J Phys Med Rehabil; 2020 Dec; 99(12):1121-1128. PubMed ID: 32520799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy].
    Cordone G; Venzano V; Rossi G; Cavallero G; Minetti C
    Pediatr Med Chir; 1984; 6(6):819-22. PubMed ID: 6545595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes of serum creatine kinase levels in children with Duchenne muscular dystrophy].
    Sun SC; Peng YS; He JB
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):35-7. PubMed ID: 18289468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA probes in Duchenne muscular dystrophy.
    Clayton J; Emery A
    Lancet; 1984 Nov; 2(8412):1151-2. PubMed ID: 6150202
    [No Abstract]   [Full Text] [Related]  

  • 17. A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy.
    Lange K; Zatz M
    Hum Hered; 1979; 29(3):154-60. PubMed ID: 468274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The female carrier of Duchenne muscular dystrophy.
    Dubowitz V
    Br Med J (Clin Res Ed); 1982 May; 284(6327):1423-4. PubMed ID: 6805547
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of discriminant analysis of serum creatine kinase levels for detection of heterozygote carriers of Duchenne muscular dystrophy].
    Krasil'nikov VV; Labeznik TA; Shilov LA
    Genetika; 1987 Jan; 23(1):176-9. PubMed ID: 3817468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early diagnosis of Duchenne muscular dystrophy by means of non selective neonatal screening].
    Martín Fernandez-Mayoralas D; San Antonio-Arce V; Campos-Castelló J
    Rev Neurol; 2002 Sep 16-30; 35(6):595-6. PubMed ID: 12389180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.